<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1673" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1673/" /><meta name="ncbi_pagename" content="Hereditary Folate Malabsorption - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hereditary Folate Malabsorption - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hereditary Folate Malabsorption" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/04/27" /><meta name="citation_author" content="David Kronn" /><meta name="citation_author" content="I David Goldman" /><meta name="citation_pmid" content="20301716" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1673/" /><meta name="citation_keywords" content="Congenital Folate Malabsorption" /><meta name="citation_keywords" content="Congenital Folate Malabsorption" /><meta name="citation_keywords" content="Proton-coupled folate transporter" /><meta name="citation_keywords" content="SLC46A1" /><meta name="citation_keywords" content="Hereditary Folate Malabsorption" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hereditary Folate Malabsorption" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="David Kronn" /><meta name="DC.Contributor" content="I David Goldman" /><meta name="DC.Date" content="2017/04/27" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1673/" /><meta name="description" content="Hereditary folate malabsorption (HFM) is characterized by folate deficiency with impaired intestinal folate absorption and impaired folate transport into the central nervous system. Findings include poor feeding, failure to thrive, and anemia. There can be leukopenia and thrombocytopenia, diarrhea and/or oral mucositis, hypoimmunoglobulinemia, and other immunologic dysfunction resulting in infections, most often Pneumocystis jerovicii pneumonia. Neurologic manifestations include developmental delays, cognitive and motor impairment, behavioral disorders and, frequently, seizures." /><meta name="og:title" content="Hereditary Folate Malabsorption" /><meta name="og:type" content="book" /><meta name="og:description" content="Hereditary folate malabsorption (HFM) is characterized by folate deficiency with impaired intestinal folate absorption and impaired folate transport into the central nervous system. Findings include poor feeding, failure to thrive, and anemia. There can be leukopenia and thrombocytopenia, diarrhea and/or oral mucositis, hypoimmunoglobulinemia, and other immunologic dysfunction resulting in infections, most often Pneumocystis jerovicii pneumonia. Neurologic manifestations include developmental delays, cognitive and motor impairment, behavioral disorders and, frequently, seizures." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1673/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/folate-mal/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1673/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D669FE0404071000000000917035F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1673_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1673_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hfpoik-tmp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hfi/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1673_"><span class="title" itemprop="name">Hereditary Folate Malabsorption</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Congenital Folate Malabsorption</div><p class="contrib-group"><span itemprop="author">David Kronn</span>, MD and <span itemprop="author">I David Goldman</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1673_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1673_ai__"><div class="contrib half_rhythm"><span itemprop="author">David Kronn</span>, MD<div class="affiliation small">Department of Pediatrics<br />New York Medical College<br />Valhalla, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmyn@nnork_divad" class="oemail">ude.cmyn@nnork_divad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">I David Goldman</span>, MD<div class="affiliation small">Departments of Medicine and Molecular Pharmacology<br />Albert Einstein College of Medicine<br />Bronx, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.uy.nietsnie@namdlog.divad.i" class="oemail">ude.uy.nietsnie@namdlog.divad.i</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 17, 2008</span>; Last Update: <span itemprop="dateModified">April 27, 2017</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="folate-mal.Summary" itemprop="description"><h2 id="_folate-mal_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Hereditary folate malabsorption (HFM) is characterized by folate deficiency with impaired intestinal folate absorption and impaired folate transport into the central nervous system. Findings include poor feeding, failure to thrive, and anemia. There can be leukopenia and thrombocytopenia, diarrhea and/or oral mucositis, hypoimmunoglobulinemia, and other immunologic dysfunction resulting in infections, most often <i>Pneumocystis jerovicii</i> pneumonia. Neurologic manifestations include developmental delays, cognitive and motor impairment, behavioral disorders and, frequently, seizures.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of HFM is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>: with anemia, impaired absorption of an oral folate load, and low cerebrospinal fluid (CSF) folate concentration (even after correction of the serum folate concentration); and/or by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC46A1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Parenteral (intramuscular) or high-dose oral 5-formyltetrahydrofolate (5-formylTHF, folinic acid, Leucovorin<sup>&#x000ae;</sup>) or the active isomer of 5-formylTHF (Isovorin<sup>&#x000ae;</sup> or Fusilev<sup>&#x000ae;</sup>) can obviate the signs and symptoms of HFM. Dosing is aimed at achieving CSF folate trough concentrations as close as possible to the normal range for the age of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual (infants and children have higher CSF folate levels than adults).</p><p><i>Prevention of primary manifestations:</i> Early treatment readily corrects the systemic folate deficiency and can achieve sufficient CSF folate levels to prevent the neurologic consequences of HFM.</p><p><i>Prevention of secondary complications:</i> In <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with selective IgA deficiency, appropriate precautions for blood product transfusion should be taken.</p><p><i>Surveillance:</i> To assess adequacy of treatment, surveillance should include: periodic complete blood counts; measurements of serum and CSF folate concentrations; measurements of serum and CSF homocysteine concentrations; and monitoring of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual&#x02019;s neurologic status. Serial measurement of immunoglobulins is not necessary once the levels return to the normal range and serum folate and hemoglobin levels remain normal and stable.</p><p><i>Agents/circumstances to avoid</i>: If possible, folic acid should not be used for the treatment of HFM because it binds very tightly to the folate receptor. This may impair transport of physiologic folates across the choroid plexus.</p><p><i>Evaluation of relatives at risk:</i> For at-risk sibs, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> when the family-specific pathogenic variants are known; otherwise, assessment of blood and CSF folate levels and, if warranted, intestinal absorption of folate immediately after birth, or as soon as the diagnosis is confirmed in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p><i>Pregnancy management:</i> Affected women should increase their folate intake above the maintenance dose prior to attempting to conceive; infants with HFM do not appear to be at an increased risk for neural malformations typically associated with maternal folate deficiency during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>HFM is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Heterozygotes (carriers) are asymptomatic and do not have clinical signs of folate deficiency. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. If both pathogenic variants have been identified in the family, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HFM are possible.</p></div></div><div id="folate-mal.Diagnosis"><h2 id="_folate-mal_Diagnosis_">Diagnosis</h2><p>Hereditary folate malabsorption (HFM) is characterized by folate deficiency with impaired intestinal folate absorption and impaired folate transport into the central nervous system [<a class="bk_pop" href="#folate-mal.REF.geller.2002.51">Geller et al 2002</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2009.e4">Zhao et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2014.310">Zhao et al 2014</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>].</p><div id="folate-mal.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Hereditary folate malabsorption (HFM) <b>should be suspected</b> in infants with the following clinical, family history, supportive laboratory, and bone marrow biopsy findings:</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Anorexia with poor weight gain and failure to thrive</div></li><li class="half_rhythm"><div>Diarrhea and/or oral mucositis</div></li><li class="half_rhythm"><div>Infections with unusual organisms (typically pneumonia caused by <i>Pneumocystis jirovecii</i>) associated with hypoimmunoglobulinemia</div></li><li class="half_rhythm"><div>Neurologic manifestations including developmental delays, cognitive and behavioral disorders, motor impairment, ataxia, and, frequently, seizures</div></li></ul><p><b>Family history</b></p><ul><li class="half_rhythm"><div>History of sib deaths in early infancy as a result of infection, anemia, and/or a seizure disorder</div></li><li class="half_rhythm"><div>Pedigree analysis consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul><p>Note: Lack of a family history of other individuals with clinical features of HFM does not preclude the diagnosis.</p><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div><b>Complete blood count</b></div><ul><li class="half_rhythm"><div class="half_rhythm">Anemia, typically with macrocytic red cell indices and macrocytosis and neutrophil hypersegmentation on peripheral smear, associated with low serum folate</div><div class="half_rhythm">Note: Normocytic anemia can be seen when there is accompanying poor nutrition and/or iron deficiency.</div></li><li class="half_rhythm"><div class="half_rhythm">In some cases, leukopenia and/or thrombocytopenia &#x02013; the latter typically mild to moderate but sometimes severe</div></li></ul></li><li class="half_rhythm"><div><b>Quantitative serum immunoglobulin levels.</b> Low concentrations of IgG, IgM, and IgA [<a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.borzutzky.2009.287">Borzutzky et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.kishimoto.2014.17">Kishimoto et al 2014</a>, <a class="bk_pop" href="#folate-mal.REF.erlacher.2015.1091">Erlacher et al 2015</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>]</div></li><li class="half_rhythm"><div><b>Erythrocyte and serum folate concentrations</b></div><ul><li class="half_rhythm"><div>Low erythrocyte folate concentration (average: ~70 ng/mL; normal: &#x0003e;200 ng/mL)</div></li><li class="half_rhythm"><div>Very low baseline serum folate concentrations in untreated individuals (typically &#x0003c;1.0 ng/mL; normal: 5-15 ng/mL, or as specified by the laboratory)</div></li><li class="half_rhythm"><div>After an oral folate load of 5-formyltetrahydrofolate (5-formylTHF or Leucovorin<sup>&#x000ae;</sup>), measurement of serum folate concentration over a minimum of four hours demonstrates little or no increase in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; in unaffected individuals the serum folate concentration increases to at least 100 ng/mL [<a class="bk_pop" href="#folate-mal.REF.lanzkowsky.1969.452">Lanzkowsky et al 1969</a>, <a class="bk_pop" href="#folate-mal.REF.santiagoborrero.1973.450">Santiago-Borrero et al 1973</a>, <a class="bk_pop" href="#folate-mal.REF.poncz.1981.76">Poncz et al 1981</a>, <a class="bk_pop" href="#folate-mal.REF.corbeel.1985.284">Corbeel et al 1985</a>, <a class="bk_pop" href="#folate-mal.REF.urbach.1987.78">Urbach et al 1987</a>, <a class="bk_pop" href="#folate-mal.REF.malatack.1999.1133">Malatack et al 1999</a>, <a class="bk_pop" href="#folate-mal.REF.geller.2002.51">Geller et al 2002</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Cerebrospinal fluid (CSF) folate concentration</b></div><ul><li class="half_rhythm"><div>Low CSF folate concentration even after correction of the serum folate concentration:</div><ul><li class="half_rhythm"><div>Baseline CSF folate concentrations in untreated <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals range from 0 to 1.5 nmol/L.</div></li><li class="half_rhythm"><div>Normal CSF folate levels are higher in infancy and through adolescence (see <a href="#folate-mal.Treatment_of_Manifestations">Treatment of Manifestations</a>).</div></li><li class="half_rhythm"><div>In unaffected adults, CSF levels are 2-3 times the normal serum folate concentration or &#x02265;10-45 nmol/L). The levels are much higher in infants and young children.</div></li></ul></li><li class="half_rhythm"><div>Following intramuscular administration of 5 mg of 5-formyltetrahydrofolate (5-formylTHF or Leucovorin<sup>&#x000ae;</sup>), the CSF folate concentration peaks transiently at one to two hours and returns to the baseline value within approximately 24 hours. However, the CSF folate concentration remains below the serum folate concentration in individuals with HFM, a finding consistent with impaired folate transport across the blood:choroid plexus:CSF barrier [<a class="bk_pop" href="#folate-mal.REF.poncz.1981.76">Poncz et al 1981</a>, <a class="bk_pop" href="#folate-mal.REF.corbeel.1985.284">Corbeel et al 1985</a>, <a class="bk_pop" href="#folate-mal.REF.malatack.1999.1133">Malatack et al 1999</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>].</div></li></ul></li></ul><p><b>Bone marrow biopsy</b></p><ul><li class="half_rhythm"><div>Evidence of megaloblastic anemia with exclusion of other causes of anemia</div></li><li class="half_rhythm"><div>Dyserythropoesis variably found</div></li></ul></div><div id="folate-mal.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of HFM <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>:</p><ul><li class="half_rhythm"><div>With anemia, impaired absorption of an oral folate load, and low cerebrospinal fluid (CSF) folate concentration (even after correction of the serum folate concentration); AND/OR</div></li><li class="half_rhythm"><div>By the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC46A1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1673/table/folate-mal.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figfolatemalTmoleculargenetictestingu" rid-ob="figobfolatemalTmoleculargenetictestingu">Table 1</a>).</div></li></ul><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SLC46A1</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SLC46A1</i> and other genes of interest (see <a href="#folate-mal.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="folate-mal.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Hereditary Folate Malabsorption</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1673/table/folate-mal.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__folate-mal.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_folate-mal.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_folate-mal.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_folate-mal.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_folate-mal.T.molecular_genetic_testing_u_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC46A1</i></td><td headers="hd_h_folate-mal.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_folate-mal.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4,&#x000a0;5,&#x000a0;6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="folate-mal.TF.1.1"><p class="no_margin">See <a href="/books/NBK1673/#folate-mal.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="folate-mal.TF.1.2"><p class="no_margin">See <a href="#folate-mal.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="folate-mal.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="folate-mal.TF.1.4"><p class="no_margin">Represents individuals from 31 families reported to date [<a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.lasry.2008.2055">Lasry et al 2008</a>, <a class="bk_pop" href="#folate-mal.REF.min.2008.435">Min et al 2008</a>, <a class="bk_pop" href="#folate-mal.REF.borzutzky.2009.287">Borzutzky et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.atabay.2010.614">Atabay et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.mahadeo.2010.c1153">Mahadeo et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.meyer.2010.325">Meyer et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.shin.2010.5162">Shin et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.mahadeo.2011.623">Mahadeo et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.shin.2011.33">Shin et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.diopbove.2013.673">Diop-Bove et al 2013</a>, <a class="bk_pop" href="#folate-mal.REF.kishimoto.2014.17">Kishimoto et al 2014</a>, <a class="bk_pop" href="#folate-mal.REF.erlacher.2015.1091">Erlacher et al 2015</a>, <a class="bk_pop" href="#folate-mal.REF.wang.2015.163">Wang et al 2015</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>]. Of these, <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants were identified in four individuals [<a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.shin.2011.33">Shin et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.kishimoto.2014.17">Kishimoto et al 2014</a>, <a class="bk_pop" href="#folate-mal.REF.wang.2015.163">Wang et al 2015</a>] ; all the other variants were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a>.</p></div></dd><dt>5. </dt><dd><div id="folate-mal.TF.1.5"><p class="no_margin">There is a common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> among individuals of Puerto Rican heritage: <a class="figpopup" href="/books/NBK1673/table/folate-mal.T.slc46a1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfolatemalTslc46a1pathogenicvariants" rid-ob="figobfolatemalTslc46a1pathogenicvariants">c.1082-1G&#x0003e;A</a>.</p></div></dd><dt>6. </dt><dd><div id="folate-mal.TF.1.6"><p class="no_margin">One variant was a deep <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 3 <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> that generated a cryptic splice donor site resulting in a 168-bp <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> [<a class="bk_pop" href="#folate-mal.REF.kishimoto.2014.17">Kishimoto et al 2014</a>]. Sequencing methodologies that can detect such variants should be considered.</p></div></dd></dl></div></div></div></div></div><div id="folate-mal.Clinical_Characteristics"><h2 id="_folate-mal_Clinical_Characteristics_">Clinical Characteristics</h2><div id="folate-mal.Clinical_Description"><h3>Clinical Description</h3><p>Hereditary folate malabsorption (HFM) is characterized by (1) impaired intestinal absorption of folates causing systemic folate deficiency and (2) impaired transport of folates across the blood:choroid plexus:CSF barrier, resulting in central nervous system folate deficiency. Infants with HFM may be born with adequate stores of folate but subsequently are unable to absorb folate from breast milk or formula and thus become folate deficient. Low serum and CSF folate concentrations were documented prior to the onset of clinical signs in a one-month old whose older sib was <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Clinical manifestations of folate deficiency have been reported as early as age two months. The age at which signs of folate deficiency appear in an infant depends at least in part on the level of folate stores accumulated in utero.</p><p><b>Anemia.</b> Folate deficiency results primarily in megaloblastic anemia but may affect all three hematopoietic lineages. The anemia may be severe and require transfusion, although with rapid diagnosis and folate repletion, transfusion should not be necessary. The anemia begins to correct within a few days after parenteral administration of folate (see <a href="#folate-mal.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p><p><b>Immunodeficiency.</b> Immunologic deficiency, which may include profound humoral and cellular immodeficiency that mimics severe combined immune deficiency, may accompany the initial manifestations of HFM. Infants with HFM and recurrent infections may die in early infancy, prior to diagnosis.</p><p>Leukopenia can be a consequence of untreated severe folate deficiency [<a class="bk_pop" href="#folate-mal.REF.malatack.1999.1133">Malatack et al 1999</a>, <a class="bk_pop" href="#folate-mal.REF.takeda.2002.666">Takeda et al 2002</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.borzutzky.2009.287">Borzutzky et al 2009</a>].</p><p>Hypoimmunoglobulinemia not associated with lymphopenia can result in infections with <i>Pneumocystis jiroveccii</i> (pneumonia), <i>C. difficile</i>, and cytomegalovirus in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants and/or their sibs, who may die in early infancy prior to diagnosis [<a class="bk_pop" href="#folate-mal.REF.malatack.1999.1133">Malatack et al 1999</a>, <a class="bk_pop" href="#folate-mal.REF.geller.2002.51">Geller et al 2002</a>, <a class="bk_pop" href="#folate-mal.REF.sofer.2007.783">Sofer et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.shin.2011.33">Shin et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.kishimoto.2014.17">Kishimoto et al 2014</a>, <a class="bk_pop" href="#folate-mal.REF.erlacher.2015.1091">Erlacher et al 2015</a>]. In one individual, absent antibody responses and lack of mitogen-induced lymphocyte proliferation occurred in conjunction with hypogammaglobulinemia; with adequate treatment, low serum IgA levels persisted while other immunologic parameters normalized [<a class="bk_pop" href="#folate-mal.REF.borzutzky.2009.287">Borzutzky et al 2009</a>].</p><p><b>Neurologic signs.</b> In some individuals with HFM, neurologic signs are part of the initial manifestations, whereas in most others, they develop later in the disease course. Neurologic features include developmental delays, cognitive and motor impairment, behavioral abnormalities, ataxia and other movement disorders, peripheral neuropathy, and seizures. It is unclear why some individuals do not have neurologic signs, as all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have very low CSF folate concentrations [<a class="bk_pop" href="#folate-mal.REF.su.1976.1128">Su 1976</a>, <a class="bk_pop" href="#folate-mal.REF.corbeel.1985.284">Corbeel et al 1985</a>, <a class="bk_pop" href="#folate-mal.REF.urbach.1987.78">Urbach et al 1987</a>, <a class="bk_pop" href="#folate-mal.REF.steinschneider.1990.1315">Steinschneider et al 1990</a>, <a class="bk_pop" href="#folate-mal.REF.malatack.1999.1133">Malatack et al 1999</a>, <a class="bk_pop" href="#folate-mal.REF.geller.2002.51">Geller et al 2002</a>, <a class="bk_pop" href="#folate-mal.REF.sofer.2007.783">Sofer et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.meyer.2010.325">Meyer et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.shin.2011.33">Shin et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>].</p><p><b>X-ray, CT, or MRI of the head.</b> Intracranial calcifications have been reported in individuals with HFM [<a class="bk_pop" href="#folate-mal.REF.lanzkowsky.1969.452">Lanzkowsky et al 1969</a>, <a class="bk_pop" href="#folate-mal.REF.corbeel.1985.284">Corbeel et al 1985</a>, <a class="bk_pop" href="#folate-mal.REF.jebnoun.2001.749">Jebnoun et al 2001</a>, <a class="bk_pop" href="#folate-mal.REF.ahmad.2015.67">Ahmad et al 2015</a>, <a class="bk_pop" href="#folate-mal.REF.wang.2015.163">Wang et al 2015</a>]. Note: Neural calcifications are also a common finding in children treated with methotrexate [<a class="bk_pop" href="#folate-mal.REF.mcintosh.1977.909">McIntosh et al 1977</a>].</p></div><div id="folate-mal.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Because of the rarity of HFM, <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have not as yet been established. Anecdotally, a benign clinical phenotype was seen in an individual (now age 36) with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic <i>SLC46A1</i> variants resulting in the complete absence of the PCFT protein, who was treated early in infancy with parenteral 5-formylTHF (see <a href="#folate-mal.Pregnancy_Management">Pregnancy Management</a>).</p></div><div id="folate-mal.Prevalence"><h3>Prevalence</h3><p>A clinical diagnosis of HFM has been reported in at least one person in 38 families to date. Of these, the diagnosis was confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in 31 families [<a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>].</p><p>The prevalence of this disorder is likely to be much greater than reflected in clinical reports to date, as infants with HFM may die undiagnosed in early infancy. This may be particularly prevalent in underdeveloped, medically underserved countries in which <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> is common.</p><p>HFM is pan ethnic. The <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency for HFM is unknown. Three carriers of the common Puerto Rican <a class="figpopup" href="/books/NBK1673/table/folate-mal.T.slc46a1_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfolatemalTslc46a1pathogenicvariants" rid-ob="figobfolatemalTslc46a1pathogenicvariants">c.1082-1G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were detected in a random screen of 1582 newborns in selected provinces in Puerto Rico [<a class="bk_pop" href="#folate-mal.REF.mahadeo.2011.623">Mahadeo et al 2011</a>].</p></div></div><div id="folate-mal.Genetically_Related_Allelic_D"><h2 id="_folate-mal_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SLC46A1</i>.</p></div><div id="folate-mal.Differential_Diagnosis"><h2 id="_folate-mal_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of hereditary folate malabsorption (HFM) includes the following.</p><p><b>Nutritional and pharmacologic</b></p><ul><li class="half_rhythm"><div>Vitamin B<sub>12</sub> deficiency as a cause of megaloblastic anemia</div></li><li class="half_rhythm"><div>Nutritional folate deficiency as a result of inadequate dietary folate</div></li><li class="half_rhythm"><div>Intestinal disease associated with folate malabsorption</div></li><li class="half_rhythm"><div>The use of phenytoin for the treatment of seizure disorders</div></li></ul><p><b>Immunologic.</b>
<a href="/books/n/gene/x-scid/">X-linked severe combined immunodeficiency</a>, a disorder resulting from <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic variants in <i>IL2RG</i></p><p><b>Inborn errors of metabolism</b></p><ul><li class="half_rhythm"><div>Glutamate formiminotransferase deficiency (OMIM <a href="http://omim.org/entry/229100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">229100</a>), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder resulting from <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FTCD</i></div></li><li class="half_rhythm"><div>Methionine synthase deficiency with megaloblastic anemia and developmental delays (see <a href="/books/n/gene/cbl/">Disorders of Intracellular Cobalamin Metabolism</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-overview/">Mitochondrial disorders</a>. A variety of mitochondrial disorders, such as <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a>, result in low CSF folate [<a class="bk_pop" href="#folate-mal.REF.p_rezdue_as.2011.615">P&#x000e9;rez-Due&#x000f1;as et al 2011</a>]. However, Kearns-Sayre syndrome has defining signs that distinguish it from HFM and the blood folate level in this and other mitochondrial disorders is normal. There is no evidence that these disorders are caused by a specific defect in a folate transporter. Impaired transport into the CSF may be due to the mitochondrial metabolic defects that impair energy metabolism and, secondarily, choroid plexus transport function</div></li></ul><p><b>Folate transporter deficiency.</b> Cerebral folate deficiency (OMIM <a href="http://omim.org/entry/613068" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613068</a>), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FOLR1</i>, which encodes the folate receptor-&#x003b1;. This condition results from impaired folate transport across the blood:choroid plexus:CSF barrier. However, individuals with cerebral folate deficiency have normal intestinal folate absorption and normal blood folate, and are not anemic. This disorder is characterized by very low CSF folate concentrations and, unlike HFM, neurologic signs typically appear several years after birth [ <a class="bk_pop" href="#folate-mal.REF.steinfeld.2009.354">Steinfeld et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.grapp.2012.2022">Grapp et al 2012</a>, <a class="bk_pop" href="#folate-mal.REF.toelle.2014.88">Toelle et al 2014</a>].</p><p><b>Malignancy.</b> Erythroleukemia</p></div><div id="folate-mal.Management"><h2 id="_folate-mal_Management_">Management</h2><div id="folate-mal.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in a child diagnosed with hereditary folate malabsorption (HFM), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div class="half_rhythm">Assessment by a pediatric neurologist to determine baseline neurologic status</div></li><li class="half_rhythm"><div class="half_rhythm">Baseline (and follow-up) formal cognitive testing</div><div class="half_rhythm">Note: Appropriate monitoring of neurologic/cognitive response to treatment is recommended to ensure that the CSF folate levels achieved with treatment are adequate.</div></li><li class="half_rhythm"><div class="half_rhythm">Initial evaluation and follow up by a metabolic genetic specialist</div></li></ul></div><div id="folate-mal.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The goal of treatment is to prevent hematologic, immunologic, and neurologic deficits and to optimize the cognitive development of children with this disorder. Complete reversal of the systemic consequences of folate deficiency is easily achieved. While correction of the neurologic consequences is more difficult, favorable neurologic outcomes are possible when adequate treatment is initiated promptly.</p><p>"Folates" refers to a family of B<sub>9</sub> vitamin compounds that are interconvertible in a series of intracellular biochemical reactions. Folate can be effective when administered by oral or parenteral routes; however, much higher oral than parenteral doses are required to correct the systemic folate deficiency. The parenteral route is probably more effective in achieving CSF folate levels appropriate to the age of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual. In either case, achieving CSF folate levels in the normal range for the age of the affected individual is challenging [<a class="bk_pop" href="#folate-mal.REF.torres.2015.91">Torres et al 2015</a>].</p><div id="folate-mal.Folate_Formulations"><h4>Folate Formulations</h4><p>Based on the current understanding of folate transport and metabolism, the following reduced folates can be used to treat HFM:</p><ul><li class="half_rhythm"><div>5-formyltetrahydrofolate (5-formylTHF), also known as folinic acid or Leucovorin<sup>&#x000ae;</sup>, is a racemic stable form of folate. The active isomer is found in low quantities in normal human tissues. Leucovorin is available in oral and parenteral formulations. There is considerable experience in dosing with this folate form (see <a href="#folate-mal.Folate_Dosing">Folate Dosing</a>).</div></li><li class="half_rhythm"><div>The active isomer of 5-formylTHF, (6S)5-formylTHF (also known as Isovorin<sup>&#x000ae;</sup> or Fusilev<sup>&#x000ae;</sup>), is available for parenteral administration. Anecdotal observations suggest that the active isomer may be more effective for treatment when there is refractory neurologic disease. The biologic impact of the active isomer is twice that of the racemic mixture when the dose is the same.</div></li><li class="half_rhythm"><div>The physiologic folate predominant in blood and tissues, (6S)5-methyltetrahydrofolate or (6S)5-methylTHF, is now available commercially as Metafolin<sup>&#x000ae;</sup> and Deplin<sup>&#x000ae;</sup>. Neither drug is available for parenteral administration. Published information on the use of (6S)5-methylTHF for the treatment of HFM is not available, although the dosing should be comparable to that of (6S)5-formylTHF. The formulation of Metafolin<sup>&#x000ae;</sup> is too low (800 &#x000b5;g) to make this agent feasible for the treatment of HFM. Deplin<sup>&#x000ae;</sup> is available as a 15-mg tablet.</div></li></ul><p>Note: If possible, folic acid should be avoided as a treatment of HFM (see <a href="#folate-mal.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>).</p></div><div id="folate-mal.Folate_Dosing"><h4>Folate Dosing</h4><p>Because HFM is rare, controlled studies to establish optimal treatment have not been possible. The oral dose of 5-formylTHF required to overcome the loss of PCFT-mediated intestinal folate absorption appears to vary from individual to individual. The dose required to obviate the neurologic consequences is much higher than that needed to correct the systemic folate deficiency. The dose should be guided by its effect on trough CSF folate concentrations. The end-point is CSF folate concentrations as close as possible to the normal range for the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual&#x02019;s age:</p><ul><li class="half_rhythm"><div class="half_rhythm">The reported oral dose of 5-formylTHF associated with a "good" outcome is approximately 150-200 mg daily [<a class="bk_pop" href="#folate-mal.REF.geller.2002.51">Geller et al 2002</a>]. Much higher doses have been used as well [personal communication to Author]. A reasonable starting oral dose of 5-formylTHF in an infant could be 50 mg or 10-15 mg/kg given daily as a single dose.</div><div class="half_rhythm">Note: Normal CSF folate is approximately 100 nmol/L for infants to age two years, decreasing to approximately 75 nmol/L by age five years and to approximately 65 nmol/L by age 19 years [<a class="bk_pop" href="#folate-mal.REF.verbeek.2008.127">Verbeek et al 2008</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">The parenteral dose required to achieve adequate blood folate levels is much lower than the oral dose. With intramuscular injections of approximately 1.0 mg/day of 5-formylTHF, the anemia will fully correct; however, the endpoint for treatment is based on the CSF folate level, which will require much higher folate doses [<a class="bk_pop" href="#folate-mal.REF.torres.2015.91">Torres et al 2015</a>].</div></li></ul></div></div><div id="folate-mal.Prevention_of_Primary_Manifes"><h3>Prevention of Primary Manifestations</h3><p>Infants diagnosed by genetic testing before signs and symptoms appear should be treated immediately to prevent the onset of folate deficiency and the metabolic and clinical consequences of the disorder.</p></div><div id="folate-mal.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p>If transfusion is required, care should be taken to administer blood products that are appropriate given the immunologic status of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual (e.g., washed packed red blood cells for those who have IgA-deficienciency).</p></div><div id="folate-mal.Surveillance"><h3>Surveillance</h3><p>The following should be monitored periodically to assess the adequacy of treatment, and more frequently following initial diagnosis when treatment is being optimized:</p><ul><li class="half_rhythm"><div>Complete blood count</div></li><li class="half_rhythm"><div>Serum and CSF folate concentrations. In particular, monitoring the trough CSF folate concentration is critical to assure that the dose of folate is sufficient to achieve CSF folate concentrations as close as possible to what is normal for the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's age.</div></li><li class="half_rhythm"><div>Neurologic/cognitive status to ensure that CSF folate levels are adequate</div></li><li class="half_rhythm"><div>Serum and CSF homocysteine concentrations. A high homocysteine concentration is the most sensitive indicator of folate deficiency.</div></li><li class="half_rhythm"><div>Serum immunoglobulin concentrations until they are within the normal range and the hemoglobin and serum folate levels are normal and stable</div></li></ul></div><div id="folate-mal.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>If possible, folic acid should be avoided as a treatment of HFM. Although folic acid is very stable and inexpensive, and is the most common pharmacologic source of folate, it is not a physiologic folate. Folic acid binds very tightly to folate receptors, which transport the physiologic folate, 5-methylTHF, into cells by an endocytic mechanism [<a class="bk_pop" href="#folate-mal.REF.kamen.2004.1085">Kamen &#x00026; Smith 2004</a>]. Thus, folic acid may interfere with the interaction between 5-methylTHF and folate receptors required for 5-methylTHF transport across the choroid plexus into the cerebrospinal fluid [<a class="bk_pop" href="#folate-mal.REF.grapp.2013.2123">Grapp et al 2013</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>].</p></div><div id="folate-mal.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Evaluations can include the following:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known. Molecular genetic testing of younger at-risk sibs who have not undergone prenatal testing should be performed immediately after birth. Those with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC46A1</i> pathogenic variants should be treated with 5-formyltetrahydrofolate immediately.</div></li><li class="half_rhythm"><div>If the pathogenic variants in the family are not known and genetic testing is not possible, assessment of blood and CSF folate levels and, if warranted, intestinal absorption of folate in at-risk sibs immediately after birth, or as soon as the diagnosis is confirmed in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></div></li></ul><p>See <a href="#folate-mal.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="folate-mal.Pregnancy_Management"><h3>Pregnancy Management</h3><p>There is no systematic information on the outcome of pregnancy in women with HFM.</p><ul><li class="half_rhythm"><div>Although the proton-coupled folate transporter (PCFT) is highly expressed in the placenta [<a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>], a woman with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants in <i>SLC46A1</i> that resulted in no PCFT protein production had two normal pregnancies and delivered two healthy infants. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> woman's parenteral 5-formylTHF dose was increased when pregnancy was planned [<a class="bk_pop" href="#folate-mal.REF.poncz.1981.76">Poncz et al 1981</a>; <a class="bk_pop" href="#folate-mal.REF.poncz.1996.948">Poncz &#x00026; Cohen 1996</a>; <a class="bk_pop" href="#folate-mal.REF.min.2008.435">Min et al 2008</a>; Goldman, personal communication to Author].</div></li></ul><p>Women with HFM who wish to become pregnant should increase their dose of 5-formylTHF intake above the maintenance dose well in advance of attempting to conceive. Prenatal vitamins are available containing 5-methylTHF rather than folic acid.</p><p>Of note, infants with HFM do not appear to be at an increased risk for malformations (e.g., neural tube defects) typically associated with maternal folate deficiency during pregnancy.</p></div><div id="folate-mal.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="folate-mal.Genetic_Counseling"><h2 id="_folate-mal_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="folate-mal.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Hereditary folate malabsorption (HFM) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="folate-mal.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are typically obligate heterozygotes (i.e., carriers of one <i>SLC46A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). Note: At least one fertile woman with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC46A1</i> had no discernable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (see <a href="#folate-mal.Pregnancy_Management">Pregnancy Management</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and do not have clinically apparent evidence of folate deficiency. It is unclear at this time whether heterozygotes may have a mild decrease in serum folate and hemoglobin.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and do not have clinically apparent evidence of folate deficiency. It is unclear at this time whether heterozygotes may have a mild decrease in serum folate and hemoglobin.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Extensive information on fertility in individuals with this disorder is not available. (See Molecular Genetics, <a href="#folate-mal.Molecular_Genetic_Pathogenesi">Molecular Genetic Pathogenesis</a>; Management, <a href="#folate-mal.Pregnancy_Management">Pregnancy Management</a>).</p><p>The offspring of an individual with HFM are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC46A1</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC46A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="folate-mal.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing of at-risk relatives requires prior identification of the <i>SLC46A</i>1 pathogenic variants in the family.</p></div><div id="folate-mal.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#folate-mal.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="folate-mal.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC46A1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HFM are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="folate-mal.Resources"><h2 id="_folate-mal_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="folate-mal.Molecular_Genetics"><h2 id="_folate-mal_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="folate-mal.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hereditary Folate Malabsorption: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1673/table/folate-mal.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__folate-mal.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_folate-mal.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_folate-mal.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_folate-mal.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_folate-mal.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_folate-mal.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_folate-mal.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_folate-mal.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/113235" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC46A1</i></a></td><td headers="hd_b_folate-mal.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=113235" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_folate-mal.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96NT5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Proton-coupled folate transporter</a></td><td headers="hd_b_folate-mal.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SLC46A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC46A1 database</a></td><td headers="hd_b_folate-mal.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC46A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC46A1</a></td><td headers="hd_b_folate-mal.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC46A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC46A1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="folate-mal.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="folate-mal.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hereditary Folate Malabsorption (<a href="/omim/229050,611672" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1673/table/folate-mal.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__folate-mal.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/229050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">229050</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FOLATE MALABSORPTION, HEREDITARY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611672" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611672</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 46 (FOLATE TRANSPORTER), MEMBER 1; SLC46A1</td></tr></tbody></table></div></div><div id="folate-mal.Molecular_Genetic_Pathogenesi"><h3>Molecular Genetic Pathogenesis</h3><p><i>SLC46A1</i>, encoding the proton-coupled folate transporter (PCFT) protein, is a member of the superfamily of solute carriers. PCFT is highly expressed at the apical membrane of the proximal jejunum and duodenum and is required for intestinal folate absorption. PCFT and folate receptor-&#x003b1; are expressed in the choroid plexus, and both appear to be required for transport of folates into the CSF [<a class="bk_pop" href="#folate-mal.REF.kamen.1991.1442">Kamen et al 1991</a>, <a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>, <a class="bk_pop" href="#folate-mal.REF.wollack.2008.1494">Wollack et al 2008</a>, <a class="bk_pop" href="#folate-mal.REF.steinfeld.2009.354">Steinfeld et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2009.e4">Zhao et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2011.177">Zhao et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.grapp.2012.2022">Grapp et al 2012</a>, <a class="bk_pop" href="#folate-mal.REF.visentin.2014.251">Visentin et al 2014</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>]. Hereditary folate malabsorption (HFM) is caused by <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>SLC46A1</i>.</p><p>A <i>Pcft</i>-null mouse, which recapitulates the hereditary folate malabsorption syndrome, was recently generated [<a class="bk_pop" href="#folate-mal.REF.salojin.2011.4895">Salojin et al 2011</a>]. Affected pups supplemented with folates develop normally and are fertile [personal communication to Author]. Similarly, <i>Pcft</i>-null mice deliver normal pups if the mother is folate sufficient [<a class="bk_pop" href="#folate-mal.REF.salojin.2011.4895">Salojin et al 2011</a>].</p><p><b>Gene structure.</b>
<i>SLC46A1</i> (<i>PCFT</i>) transcript is approximately 6.5 kb (<a href="/nuccore/NM_080669.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_080669.5</a>) and has five exons. This transcript variant is the longest of the 2.7 kb and 2.1 kb that have been detected [<a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1673/#folate-mal.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>SLC46A1</i> pathogenic variants reported to date are distributed in exons 1-4. A common site of mutation is in a G-C rich region of the first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>, which encodes the first extracellular loop separating the first and second transmembrane domains. <i>SLC46A1</i> pathogenic variants encompass insertions, frame shifts, a stop codon, and a splice variant.</p><p>While most identified pathogenic variants have been novel (i.e., seen in only one family), the c.1082-1G&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported in ten apparently unrelated families of Puerto Rican ancestry [<a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>]. This pathogenic variant, located in the splice acceptor of <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 2, causes skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3. The protein was produced in a cell line transfected with the variant but was not detectable in the cell membrane, consistent with a trafficking defect [<a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>].</p><div id="folate-mal.T.slc46a1_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>SLC46A1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1673/table/folate-mal.T.slc46a1_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__folate-mal.T.slc46a1_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.439G&#x0003e;C</td><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly147Arg</td><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_080669.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_080669<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/protein/NP_542400.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_542400<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1082-1G&#x0003e;A</td><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr362_Gly389del&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1127G&#x0003e;A</td><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg376Gln</td></tr><tr><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1274C&#x0003e;G</td><td headers="hd_h_folate-mal.T.slc46a1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro425Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="folate-mal.TF.2.1"><p class="no_margin">In-frame <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> resulting from skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 was detected in <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> from transformed lymphocytes of individuals with HFM [<a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>]; the resulting transcript variant is <a href="https://www.ncbi.nlm.nih.gov/nuccore/BC010691" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BC01069<wbr style="display:inline-block"></wbr>​.1</a>. The same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has now been identified in a total of ten unrelated families of Puerto Rican ancestry [<a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>, <a class="bk_pop" href="#folate-mal.REF.borzutzky.2009.287">Borzutzky et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.mahadeo.2011.623">Mahadeo et al 2011</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2017.57">Zhao et al 2017</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The proton-coupled folate transporter (PCFT) is predicted to have 459 amino acids with a MW of approximately 50 kd. Hydropathy analysis predicted a protein with twelve transmembrane domains [ <a class="bk_pop" href="#folate-mal.REF.qiu.2006.917">Qiu et al 2006</a>, <a class="bk_pop" href="#folate-mal.REF.nakai.2007.469">Nakai et al 2007</a>, <a class="bk_pop" href="#folate-mal.REF.qiu.2007.c1669">Qiu et al 2007</a>]. This secondary structure has now been confirmed by the substituted cysteine accessibility method [<a class="bk_pop" href="#folate-mal.REF.zhao.2010.2925">Zhao et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.duddempudi.2013.e78301">Duddempudi et al 2013</a>, <a class="bk_pop" href="#folate-mal.REF.date.2016.216">Date et al 2016</a>]. PCFT has high affinity for folic acid, reduced folates, and anti-folates and has a low pH optimum [<a class="bk_pop" href="#folate-mal.REF.zhao.2009.e4">Zhao et al 2009</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2011.177">Zhao et al 2011</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Single-nucleotide variants within transmembrane domains, causing amino acid substitutions, result in unstable proteins or proteins with markedly impaired function. Some of the mutated proteins trafficked to the cell membrane and some did not. In three cases (p.Gly147Arg, p.Pro425Arg, p.Arg376Gln) [<a class="bk_pop" href="#folate-mal.REF.mahadeo.2010.c1153">Mahadeo et al 2010</a>, <a class="bk_pop" href="#folate-mal.REF.zhao.2007.1147">Zhao et al 2007</a>], mutated <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> had residual transport activity upon transfection into HeLa cells null for constitutive folate-specific transporters.</p></div></div><div id="folate-mal.References"><h2 id="_folate-mal_References_">References</h2><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.ahmad.2015.67">Ahmad I, Mukhtar G, Iqbal J, Ali S W. Hereditary folate malabsorption with extensive intracranial calcification. <span><span class="ref-journal">Indian Pediatr. </span>2015;<span class="ref-vol">52</span>:67–8.</span> [<a href="/pubmed/25638192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25638192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.atabay.2010.614">Atabay B, Turker M, Ozer EA, Mahadeo K, Diop-Bove N, Goldman ID. Mutation of the proton-coupled folate transporter gene (PCFT-SLC46A1) in Turkish siblings with hereditary folate malabsorption. <span><span class="ref-journal">Pediatr Hematol Oncol. </span>2010;<span class="ref-vol">27</span>:614–9.</span> [<a href="/pmc/articles/PMC3885236/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3885236</span></a>] [<a href="/pubmed/20795774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20795774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.borzutzky.2009.287">Borzutzky A, Crompton B, Bergmann AK, Giliani S, Baxi S, Martin M, Neufeld EJ, Notarangelo LD. Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter. <span><span class="ref-journal">Clin Immunol. </span>2009;<span class="ref-vol">133</span>:287–94.</span> [<a href="/pmc/articles/PMC2783538/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2783538</span></a>] [<a href="/pubmed/19740703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19740703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.corbeel.1985.284">Corbeel L, Van den Berghe G, Jaeken J, Van Tornout J, Eeckels R. Congenital folate malabsorption. <span><span class="ref-journal">Eur J Pediatr. </span>1985;<span class="ref-vol">143</span>:284–90.</span> [<a href="/pubmed/3987728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3987728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.date.2016.216">Date SS, Chen CS, Chen Y, Jansen M. Experimentally optimized threading structure of the proton-coupled folate transporter. <span><span class="ref-journal">FEBS Open Bio. </span>2016;<span class="ref-vol">6</span>:216–30.</span> [<a href="/pmc/articles/PMC4794783/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4794783</span></a>] [<a href="/pubmed/27047750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27047750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.diopbove.2013.673">Diop-Bove N, Jain M, Scaglia F, Goldman ID. A novel deletion mutation in the proton-coupled folate transporter (PCFT; SLC46A1) in a Nicaraguan child with hereditary folate malabsorption. <span><span class="ref-journal">Gene. </span>2013;<span class="ref-vol">527</span>:673–4.</span> [<a href="/pmc/articles/PMC3836604/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3836604</span></a>] [<a href="/pubmed/23816405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23816405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.duddempudi.2013.e78301">Duddempudi PK, Goyal R, Date SS, Jansen M. Delineating the extracellular water-accessible surface of the proton-coupled folate transporter. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e78301.</span> [<a href="/pmc/articles/PMC3799626/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3799626</span></a>] [<a href="/pubmed/24205192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24205192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.erlacher.2015.1091">Erlacher M, Grunert SC, Cseh A, Steinfeld R, Salzer U, Lausch E, Nosswitz U, Duckers G, Niehues T, Ehl S, Niemeyer CM, Speckmann C. Reversible pancytopenia and immunodeficiency in a patient with hereditary folate malabsorption. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2015;<span class="ref-vol">62</span>:1091–4.</span> [<a href="/pubmed/25504888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25504888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.geller.2002.51">Geller J, Kronn D, Jayabose S, Sandoval C. Hereditary folate malabsorption: family report and review of the literature. <span><span class="ref-journal">Medicine (Baltimore). </span>2002;<span class="ref-vol">81</span>:51–68.</span> [<a href="/pubmed/11807405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11807405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.grapp.2012.2022">Grapp M, Just IA, Linnankivi T, Wolf P, Lucke T, Hausler M, Gartner J, Steinfeld R. Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:2022–31.</span> [<a href="/pubmed/22586289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22586289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.grapp.2013.2123">Grapp M, Wrede A, Schweizer M, Huwel S, Galla HJ, Snaidero N, Simons M, Buckers J, Low PS, Urlaub H, Gartner J, Steinfeld R. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. <span><span class="ref-journal">Nat Commun. </span>2013;<span class="ref-vol">4</span>:2123.</span> [<a href="/pubmed/23828504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23828504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.jebnoun.2001.749">Jebnoun S, Kacem S, Mokrani CH, Chabchoub A, Khrouf N, Zittoun J. A family study of congenital malabsorption of folate. <span><span class="ref-journal">J Inherit Metab Dis. </span>2001;<span class="ref-vol">24</span>:749–50.</span> [<a href="/pubmed/11804211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11804211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.kamen.2004.1085">Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2004;<span class="ref-vol">56</span>:1085–97.</span> [<a href="/pubmed/15094208" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15094208</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.kamen.1991.1442">Kamen BA, Smith AK, Anderson RGW. The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro. <span><span class="ref-journal">J Clin Invest. </span>1991;<span class="ref-vol">87</span>:1442–9.</span> [<a href="/pmc/articles/PMC295193/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC295193</span></a>] [<a href="/pubmed/1849150" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1849150</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.kishimoto.2014.17">Kishimoto K, Kobayashi R, Sano H, Suzuki D, Maruoka H, Yasuda K, Chida N, Yamada M, Kobayashi K. Impact of folate therapy on combined immunodeficiency secondary to hereditary folate malabsorption. <span><span class="ref-journal">Clin Immunol. </span>2014;<span class="ref-vol">153</span>:17–22.</span> [<a href="/pubmed/24691418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24691418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.lanzkowsky.1969.452">Lanzkowsky P, Erlandson ME, Bezan AI. Isolated defect of folic acid absorption associated with mental retardation and cerebral calcification. <span><span class="ref-journal">Blood. </span>1969;<span class="ref-vol">34</span>:452–65.</span> [<a href="/pubmed/4980683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4980683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.lasry.2008.2055">Lasry I, Berman B, Straussberg R, Sofer Y, Bessler H, Sharkia M, Glaser F, Jansen G, Drori S, Assaraf YG. A novel loss of function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">112</span>:2055–61.</span> [<a href="/pubmed/18559978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18559978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.mahadeo.2010.c1153">Mahadeo K, Diop-Bove N, Shin D, Unal E, Teo J, Zhao R, Chang MH, Fulterer A, Romero MF, Goldman ID. Properties of the Arg376 residue of the proton-coupled folate transporter (PCFT-SLC46A1) and a glutamine mutant causing hereditary folate malabsorption. <span><span class="ref-journal">Am J Physiol Cell Physiol. </span>2010;<span class="ref-vol">299</span>:C1153–C1161.</span> [<a href="/pmc/articles/PMC2980313/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2980313</span></a>] [<a href="/pubmed/20686069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20686069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.mahadeo.2011.623">Mahadeo KM, Diop-Bove N, Ramirez SI, Cadilla CL, Rivera E, Martin M, Lerner NB, DiAntonio L, Duva S, Santiago-Borrero PJ, Goldman I D. Prevalence of a loss-of-function mutation in the proton-coupled folate transporter gene (PCFT-SLC46A1) causing hereditary folate malabsorption in Puerto Rico. <span><span class="ref-journal">J Pediatr. </span>2011;<span class="ref-vol">159</span>:623–7.e1.</span> [<a href="/pmc/articles/PMC3935241/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3935241</span></a>] [<a href="/pubmed/21489556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21489556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.malatack.1999.1133">Malatack JJ, Moran MM, Moughan B. Isolated congenital malabsorption of folic acid in a male infant: insights into treatment and mechanism of defect. <span><span class="ref-journal">Pediatrics. </span>1999;<span class="ref-vol">104</span>:1133–7.</span> [<a href="/pubmed/10545560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10545560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.mcintosh.1977.909">McIntosh S, Fischer DB, Rothman SG, Rosenfield N, Lobel JS, O'Brien R. Intracranial calcifications in childhood leukemia. an association with systemic chemotherapy. <span><span class="ref-journal">J Pediatr. </span>1977;<span class="ref-vol">91</span>:909–13.</span> [<a href="/pubmed/925819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 925819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.meyer.2010.325">Meyer E, Kurian MA, Pasha S, Trembath RC, Cole T, Maher ER. A novel PCFT gene mutation (p.Cys66LeufsX99) causing hereditary folate malabsorption. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">99</span>:325–8.</span> [<a href="/pmc/articles/PMC2852677/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2852677</span></a>] [<a href="/pubmed/20005757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20005757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.min.2008.435">Min SH, Oh SY, Karp GI, Poncz M, Zhao R, Goldman ID. The clinical course and genetic defect in the PCFT in a 27-year-old woman with hereditary folate malabsorption. <span><span class="ref-journal">J Pediatr. </span>2008;<span class="ref-vol">153</span>:435–7.</span> [<a href="/pmc/articles/PMC3835188/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3835188</span></a>] [<a href="/pubmed/18718264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18718264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.nakai.2007.469">Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, Hayashi Y, Yuasa H. Functional characterization of human PCFT/HCP1 heterologously expressed in mammalian cells as a folate transporter. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2007;<span class="ref-vol">322</span>:469–76.</span> [<a href="/pubmed/17475902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17475902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.p_rezdue_as.2011.615">P&#x000e9;rez-Due&#x000f1;as B, Ormazabal A, Toma C, Torrico B, Cormand B, Serrano M, Sierra C, De GE, Marfa MP, Garcia-Cazorla A, Campistol J, Pascual JM, Artuch R. Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects. <span><span class="ref-journal">Arch Neurol. </span>2011;<span class="ref-vol">68</span>:615–21.</span> [<a href="/pubmed/21555636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21555636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.poncz.1996.948">Poncz M, Cohen A. Long-term treatment of congenital folate malabsorption. <span><span class="ref-journal">J Pediatr. </span>1996;<span class="ref-vol">129</span>:948.</span> [<a href="/pubmed/8969750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8969750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.poncz.1981.76">Poncz M, Colman N, Herbert V, Schwartz E, Cohen AR. Therapy of congenital folate malabsorption. <span><span class="ref-journal">J Pediatr. </span>1981;<span class="ref-vol">98</span>:76–9.</span> [<a href="/pubmed/6969796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6969796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.qiu.2006.917">Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">127</span>:917–28.</span> [<a href="/pubmed/17129779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17129779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.qiu.2007.c1669">Qiu A, Min SH, Jansen M, Malhotra U, Tsai E, Cabelof DC, Matherly LH, Zhao R, Akabas MH, Goldman ID. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. <span><span class="ref-journal">Am J Physiol Cell Physiol. </span>2007;<span class="ref-vol">293</span>:C1669–C1678.</span> [<a href="/pubmed/17898134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17898134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.salojin.2011.4895">Salojin KV, Cabrera RM, Sun W, Chang WC, Lin C, Duncan L, Platt KA, Read R, Vogel P, Liu Q, Finnell RH, Oravecz T. A mouse model of hereditary folate malabsorption: deletion of the PCFT gene leads to systemic folate deficiency. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">117</span>:4895–904.</span> [<a href="/pubmed/21346251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21346251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.santiagoborrero.1973.450">Santiago-Borrero PJ, Santini R Jr, Perez-Santiago E, Maldonado N. Congenital isolated defect of folic acid absorption. <span><span class="ref-journal">J Pediatr. </span>1973;<span class="ref-vol">82</span>:450–5.</span> [<a href="/pubmed/4540608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4540608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.shin.2011.33">Shin DS, Mahadeo K, Min SH, Diop-Bove N, Clayton P, Zhao R, Goldman ID. Identification of novel mutations in the proton-coupled folate transporter (PCFT-SLC46A1) associated with hereditary folate malabsorption. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">103</span>:33–7.</span> [<a href="/pmc/articles/PMC3081934/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3081934</span></a>] [<a href="/pubmed/21333572" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21333572</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.shin.2010.5162">Shin DS, Min SH, Russell L, Zhao R, Fiser A, Goldman ID. Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT; SLC46A1); a D156Y mutation causing hereditary folate malabsorption. <span><span class="ref-journal">Blood. </span>2010;<span class="ref-vol">116</span>:5162–9.</span> [<a href="/pmc/articles/PMC3012536/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3012536</span></a>] [<a href="/pubmed/20805364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20805364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.sofer.2007.783">Sofer Y, Harel L, Sharkia M, Amir J, Schoenfeld T, Straussberg R. Neurological manifestations of folate transport defect: case report and review of the literature. <span><span class="ref-journal">J Child Neurol. </span>2007;<span class="ref-vol">22</span>:783–6.</span> [<a href="/pubmed/17641272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17641272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.steinfeld.2009.354">Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, Wevers R, Grosso S, Gartner J. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:354–63.</span> [<a href="/pmc/articles/PMC2771535/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2771535</span></a>] [<a href="/pubmed/19732866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19732866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.steinschneider.1990.1315">Steinschneider M, Sherbany A, Pavlakis S, Emerson R, Lovelace R, De Vivo D C. Congenital folate malabsorption: reversible clinical and neurophysiologic abnormalities. <span><span class="ref-journal">Neurology. </span>1990;<span class="ref-vol">40</span>:1315.</span> [<a href="/pubmed/2381546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2381546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.su.1976.1128">Su PC. Letter: congenital folate deficiency. <span><span class="ref-journal">N Engl J Med. </span>1976;<span class="ref-vol">294</span>:1128.</span> [<a href="/pubmed/176588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 176588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.takeda.2002.666">Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2002;<span class="ref-vol">302</span>:666–71.</span> [<a href="/pubmed/12130730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12130730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.toelle.2014.88">Toelle SP, Wille D, Schmitt B, Scheer I, Thony B, Plecko B. Sensory stimulus-sensitive drop attacks and basal ganglia calcification: new findings in a patient with FOLR1 deficiency. <span><span class="ref-journal">Epileptic Disord. </span>2014;<span class="ref-vol">16</span>:88–92.</span> [<a href="/pubmed/24556562" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24556562</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.torres.2015.91">Torres A, Newton SA, Crompton B, Borzutzky A, Neufeld EJ, Notarangelo L, Berry GT. CSF 5-methyltetrahydrofolate serial monitoring to guide treatment of congenital folate malabsorption due to proton-coupled folate transporter (PCFT) deficiency. <span><span class="ref-journal">JIMD Rep. </span>2015;<span class="ref-vol">24</span>:91–6.</span> [<a href="/pmc/articles/PMC4582027/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4582027</span></a>] [<a href="/pubmed/26006721" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26006721</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.urbach.1987.78">Urbach J, Abrahamov A, Grossowicz N. Congenital isolated folic acid malabsorption. <span><span class="ref-journal">Arch Dis Child. </span>1987;<span class="ref-vol">62</span>:78–80.</span> [<a href="/pmc/articles/PMC1778153/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1778153</span></a>] [<a href="/pubmed/3813642" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3813642</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.verbeek.2008.127">Verbeek MM, Blom AM, Wevers RA, Lagerwerf AJ, van de Geer J, Willemsen MA. Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">95</span>:127–32.</span> [<a href="/pubmed/18722797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18722797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.visentin.2014.251">Visentin M, Diop-Bove N, Zhao R, Goldman ID. The intestinal absorption of folates. <span><span class="ref-journal">Annu Rev Physiol. </span>2014;<span class="ref-vol">76</span>:251–74.</span> [<a href="/pmc/articles/PMC3982215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3982215</span></a>] [<a href="/pubmed/24512081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24512081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.wang.2015.163">Wang Q, Li X, Ding Y, Liu Y, Qin Y, Yang Y. The first chinese case report of hereditary folate malabsorption with a novel mutation on SLC46A1. <span><span class="ref-journal">Brain Dev. </span>2015;<span class="ref-vol">37</span>:163–7.</span> [<a href="/pubmed/24534056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24534056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.wollack.2008.1494">Wollack JB, Makori B, Ahlawat S, Koneru R, Picinich SC, Smith A, Goldman ID, Qiu A, Cole PD, Glod J, Kamen B. Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. <span><span class="ref-journal">J Neurochem. </span>2008;<span class="ref-vol">104</span>:1494–503.</span> [<a href="/pubmed/18086128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18086128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.zhao.2017.57">Zhao R, Aluri S, Goldman ID. The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: hereditary folate malabsorption. <span><span class="ref-journal">Mol Aspects Med. </span>2017;<span class="ref-vol">53</span>:57–72.</span> [<a href="/pmc/articles/PMC5253092/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5253092</span></a>] [<a href="/pubmed/27664775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27664775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.zhao.2014.310">Zhao R, Diop-Bove N, Goldman ID. Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression. <span><span class="ref-journal">Mol Pharmacol. </span>2014;<span class="ref-vol">85</span>:310–21.</span> [<a href="/pmc/articles/PMC3913358/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3913358</span></a>] [<a href="/pubmed/24249723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24249723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.zhao.2011.177">Zhao R, Diop-Bove N, Visentin M, Goldman ID. Mechanisms of membrane transport of folates into cells and across epithelia. <span><span class="ref-journal">Annu Rev Nutr. </span>2011;<span class="ref-vol">31</span>:177–201.</span> [<a href="/pmc/articles/PMC3885234/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3885234</span></a>] [<a href="/pubmed/21568705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21568705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.zhao.2009.e4">Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. <span><span class="ref-journal">Expert Rev Mol Med. </span>2009;<span class="ref-vol">11</span>:e4.</span> [<a href="/pmc/articles/PMC3770294/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3770294</span></a>] [<a href="/pubmed/19173758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19173758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.zhao.2007.1147">Zhao R, Min SH, Qiu A, Sakaris A, Goldberg GL, Sandoval C, Malatack JJ, Rosenblatt DS, Goldman ID. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">110</span>:1147–52.</span> [<a href="/pmc/articles/PMC1939898/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1939898</span></a>] [<a href="/pubmed/17446347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17446347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="folate-mal.REF.zhao.2010.2925">Zhao R, Unal ES, Shin DS, Goldman ID. Membrane topological analysis of the proton-coupled folate transporter (PCFT-SLC46A1) by the substituted cysteine accessibility method. <span><span class="ref-journal">Biochemistry. </span>2010;<span class="ref-vol">49</span>:2925–31.</span> [<a href="/pmc/articles/PMC2866095/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2866095</span></a>] [<a href="/pubmed/20225891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20225891</span></a>]</div></li></ul></div><div id="folate-mal.Chapter_Notes"><h2 id="_folate-mal_Chapter_Notes_">Chapter Notes</h2><div id="folate-mal.Author_History"><h3>Author History</h3><p>Ndeye Diop-Bove, PhD; Albert Einstein College of Medicine (2010-2017)<br />I David Goldman, MD (2008-present)<br />David Kronn, MD (2008-present)<br />Kris M Mahadeo, MD, MPH; Albert Einstein College of Medicine (2010-2011)<br />Sang Hee Min, MD; Albert Einstein College of Medicine (2008-2011)<br />Claudio Sandoval, MD; New York Medical College (2008-2010)</p></div><div id="folate-mal.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>27 April 2017 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 June 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 December 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 May 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 June 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>4 March 2008 (idg) Initial submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1673</span><span class="label">PMID: <a href="/pubmed/20301716" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301716</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hfpoik-tmp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hfi/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1673&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1673/?report=reader">PubReader</a></li><li><a href="/books/NBK1673/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1673" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1673" style="display:none" title="Cite this Page"><div class="bk_tt">Kronn D, Goldman ID. Hereditary Folate Malabsorption. 2008 Jun 17 [Updated 2017 Apr 27]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1673/pdf/Bookshelf_NBK1673.pdf">PDF version of this page</a> (451K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#folate-mal.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#folate-mal.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#folate-mal.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#folate-mal.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#folate-mal.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#folate-mal.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#folate-mal.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#folate-mal.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#folate-mal.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#folate-mal.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#folate-mal.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=113235[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC46A1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1673+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1490276" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1490276" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1490276" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1490276" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301503" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sloan JL, Carrillo N, Adams D, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301599" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Thalassemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Thalassemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Origa R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301360" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saheki T, Song YZ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24624460" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kalfa TA, Connor JA, Begtrup AH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301716" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301716" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04196575f66d18aa982fb9">Hereditary Folate Malabsorption - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hereditary Folate Malabsorption - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:22:29-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D669FE0404071000000000917035F&amp;ncbi_session=CE8D669FE0419641_2327SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1673%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1673&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1673/&amp;ncbi_pagename=Hereditary Folate Malabsorption - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D669FE0419641_2327SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>